ES2068883T3 - Vacunas combinadas vivas. - Google Patents

Vacunas combinadas vivas.

Info

Publication number
ES2068883T3
ES2068883T3 ES89200382T ES89200382T ES2068883T3 ES 2068883 T3 ES2068883 T3 ES 2068883T3 ES 89200382 T ES89200382 T ES 89200382T ES 89200382 T ES89200382 T ES 89200382T ES 2068883 T3 ES2068883 T3 ES 2068883T3
Authority
ES
Spain
Prior art keywords
combined vaccines
live combined
live
viruses
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89200382T
Other languages
English (en)
Inventor
Carla Christina Schrier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2068883T3 publication Critical patent/ES2068883T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE SOBRE VACUNAS COMBINADAS VIVAS PARA INMUNIZAR AVES COMPRENDIENDO AL MENOS DOS VIRUS DIFERENTES, EN DONDE AL MENOS UNO DE LOS VIRUS ES UN VIRUS DE LA BRONQUITIS INFECCIOSA MOSTRANDO LA PROPIEDAD DE HEMOAGLUTINAR ESPONTANEAMENTE ERITROCITOS DE GALLINA.
ES89200382T 1988-03-08 1989-02-17 Vacunas combinadas vivas. Expired - Lifetime ES2068883T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/165,339 US5037650A (en) 1988-03-08 1988-03-08 Live combination vaccine

Publications (1)

Publication Number Publication Date
ES2068883T3 true ES2068883T3 (es) 1995-05-01

Family

ID=22598508

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89200382T Expired - Lifetime ES2068883T3 (es) 1988-03-08 1989-02-17 Vacunas combinadas vivas.

Country Status (13)

Country Link
US (1) US5037650A (es)
EP (1) EP0332241B1 (es)
JP (2) JP2721005B2 (es)
KR (1) KR920005661B1 (es)
CN (2) CN1036838C (es)
AT (1) ATE116551T1 (es)
AU (1) AU614035B2 (es)
CA (1) CA1339963C (es)
DE (1) DE68920345T2 (es)
ES (1) ES2068883T3 (es)
HU (1) HU205265B (es)
NZ (1) NZ228232A (es)
ZA (1) ZA891371B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA978434B (en) * 1996-09-27 1998-03-26 Akzo Nobel Nv Inactivated vaccines.
KR100468037B1 (ko) * 2002-01-04 2005-01-24 학교법인 건국대학교 신규한 닭 전염성 기관지염 바이러스(ｉｂｖ) 및 이를이용한 닭 전염성 기관지염 (ｉｂ) 감염 예방백신
CN101374547A (zh) * 2005-12-22 2009-02-25 财团法人化学及血清疗法研究所 卵内接种用疫苗
GB2451428A (en) * 2007-07-25 2009-02-04 Pliva Hrvatska D O O Process for preparing an in ovo combination viral vaccine
AR072976A1 (es) * 2008-08-08 2010-10-06 Wyeth Corp Virus de bronquitis infecciosa (ib) aislado, composicion de vacuna y metodo para preparar un virus de bronquitis infecciosa (ib) atenuado vivo
CA2725435C (en) 2009-12-15 2023-01-03 University Of Saskatchewan Vaccines for inclusion body hepatitis
GB201601498D0 (en) 2016-01-27 2016-03-09 Pirbright Inst The Coronavirus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798835A (en) * 1954-01-18 1957-07-09 American Cyanamid Co Newcastle disease and infectious bronchitis vaccines and production thereof
JPS587611B2 (ja) * 1973-07-26 1983-02-10 ザイダンホウジン カガクオヨビケツセイリヨウホウケンキユウシヨ カキンヨウコンゴウナマワクチン ノ セイゾウホウホウ
JPS54132226A (en) * 1978-04-04 1979-10-15 Biseibutsu Kagaku Kenkiyuushiy Raw virus vaccine for poutly infecting laryngth bronchus imflammatory
GB2114438A (en) * 1982-02-05 1983-08-24 Akzo Nv Infectious bronchitis vaccines
EP0212703B1 (en) * 1985-07-18 1991-09-04 Duphar International Research B.V Infectious bronchitis vaccines for day-old chickens

Also Published As

Publication number Publication date
DE68920345D1 (de) 1995-02-16
HUT52704A (en) 1990-08-28
AU3115189A (en) 1989-09-14
DE68920345T2 (de) 1995-05-24
CN1036838C (zh) 1997-12-31
JP2721005B2 (ja) 1998-03-04
JPH10175881A (ja) 1998-06-30
AU614035B2 (en) 1991-08-15
JPH01272529A (ja) 1989-10-31
CN1037838A (zh) 1989-12-13
CN1101289A (zh) 1995-04-12
EP0332241A2 (en) 1989-09-13
HU205265B (en) 1992-04-28
US5037650A (en) 1991-08-06
EP0332241B1 (en) 1995-01-04
NZ228232A (en) 1991-08-27
JP2887251B2 (ja) 1999-04-26
ATE116551T1 (de) 1995-01-15
KR890014127A (ko) 1989-10-21
ZA891371B (en) 1989-11-29
EP0332241A3 (en) 1990-05-16
KR920005661B1 (ko) 1992-07-13
CA1339963C (en) 1998-07-21

Similar Documents

Publication Publication Date Title
MX9304571A (es) Compuestos fanilicos ligados a un arilo o heteroarilo mediante un radical alifatico o un atomo heterogeneo que contiene un grupo eslabonador.
FI871362L (fi) Virusvaccin.
YU74292A (sh) Jedinjenja za inhibiciju hiv i srodnih virusa
ES2057191T5 (es) Metodo de produccion para una composicion que contiene proteinas.
ATE79548T1 (de) Herpes simplex virus subunitimpfstoff.
ES2061609T3 (es) 2',3'-dideoxi-2'-fluoro-nucleosidos.
ES490210A0 (es) Un procedimiento par la preparacion de una vacuna de la gri-pe.
ES2074323T3 (es) Nuevos derivados de piridilo, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
IL54390A (en) Live newcastle disease virus vaccine
ES2148355T3 (es) Procedimiento para la preparacion de nevirapina.
ES2031357T3 (es) Metodo de preparar una combinacion antiviral.
PT838222E (pt) Composicoes de vacina compreendendo imunogenios inactivados e virus da anemia dagalinha (cav) vivos
ES2032339T3 (es) Procedimiento para preparar nuevos compuestos de indolilpiperidina.
ES467557A1 (es) Un procedimiento para la preparacion de una nueva vacuna queprotege a las aves ponedoras de huevos contra la enfermedad del descenso de la produccion de huevos.
ES500199A0 (es) Un procedimiento para preparar una vacuna de virus de la ra-bia inactivados
DK0533294T3 (da) Kyllingeanæmiagensvaccine.
ATE122235T1 (de) Staupevirus-impfstoff.
ES2058100T3 (es) Vacuna combinada.
DK147889C (da) Fremgangsmaade til dyrkning af virus
ATE116551T1 (de) Lebendes kombinationsvakzin.
DK307080A (da) Fremgangsmaade til fremstilling af en ny polyvalent virusvaccine
DK547279A (da) E fremgangsmaade til fremstilling af inaktiveret reovirusvaccin
ES2063048T3 (es) Vacuna para proteccion de gatos contra la peritonitis infecciosa felina.
DK159377C (da) Fremgangsmaade til fremstilling af en sammensaetning til forebyggelse eller behandling af kraeft
ES2088458T3 (es) Fraccion antiviral de extracto acuoso de lentinus edodes.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 332241

Country of ref document: ES